Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and pharmacokinetics of a 40% lidocaine topical gel versus placebo for acute herpes zoster pain, sponsored by Centrexion T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Lidocaine 40% topical gel (lidocaine)

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Acute-onset Herpes Zoster Pain | Phase 1 | Status: TERMINATED